US · Healthcare

Gemina Laboratories Ltd (GLABF)

Biotechnology

Gemina Laboratories Ltd (GLABF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GLABF

P/E ratio

25.00

Gemina Laboratories Ltd (GLABF) — FAQ

What is GLABF's P/E ratio?

The price-to-earnings (P/E) ratio for Gemina Laboratories Ltd (GLABF) is 25.00 (data as of 2026-05-23).

Does Gemina Laboratories Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Gemina Laboratories Ltd (GLABF). Check the MyAverix Finance app for the latest dividend data.

What sector is Gemina Laboratories Ltd in?

Gemina Laboratories Ltd (GLABF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GLABF listed on?

GLABF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)